Featured Insights and Perspectives from Darwin

The latest insights, ideas, and perspectives from Darwin, updated bianually. Explore a cross-section of up-to-date content from us and other thought leaders on trends in health care, research, and data.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

News and Insights

Showing items 1 to3 of 6

Categories
Tags
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Our Take: CMS introduces new oncology care model, proposes changes to Medicare Shared Savings Program
Insight
Our Take Newsletter
July 11, 2022

Our Take: CMS introduces new oncology care model, proposes changes to Medicare Shared Savings Program

Learn More
July 11, 2022
CMS
hospital market concentrations
medicare
medicine
drugs.medicine
Our Take: Northwell Health, New York-Presbyterian form separate partnerships to advance patient care through AI
Insight
Our Take Newsletter
July 18, 2022

Our Take: Northwell Health, New York-Presbyterian form separate partnerships to advance patient care through AI

Learn More
July 18, 2022
blue cross blue shield of north carolina
new york university
partners
health
healthcare
Our Take: Amazon plans to acquire primary care provider One Medical for $3.9 billion
Insight
Our Take Newsletter
July 25, 2022

Our Take: Amazon plans to acquire primary care provider One Medical for $3.9 billion

Learn More
July 25, 2022
amazon
amazon care
primary care
medicare
Our Take: Humana to streamline its operations into two units: Insurance Services and CenterWell
Insight
Our Take Newsletter
August 1, 2022

Our Take: Humana to streamline its operations into two units: Insurance Services and CenterWell

Learn More
August 1, 2022
Humana
chief operating officer
community-based
health care service corp
Our Take: CVS could make major primary care acquisition by year-end, execs suggest on earnings call
Insight
Our Take Newsletter
August 8, 2022

Our Take: CVS could make major primary care acquisition by year-end, execs suggest on earnings call

Learn More
August 8, 2022
primary care
CVS
CVS Health
health
virtual primary care
Our Take: HCA Healthcare partners with J&J to improve health equity, patient outcomes, support for nurses
Insight
Our Take Newsletter
August 15, 2022

Our Take: HCA Healthcare partners with J&J to improve health equity, patient outcomes, support for nurses

Learn More
August 15, 2022
healthcare
partners
hospital
health plan
Our Take: Health systems continue to report dismal financial results in Q2, blunted by labor expenses and poor investment performance
Insight
Our Take Newsletter
August 22, 2022

Our Take: Health systems continue to report dismal financial results in Q2, blunted by labor expenses and poor investment performance

Learn More
August 22, 2022
health
finance
financials
healthcare
Our Take: Amazon takes a U-turn and decides to shut down Amazon Care
Insight
Our Take Newsletter
August 29, 2022

Our Take: Amazon takes a U-turn and decides to shut down Amazon Care

Learn More
August 29, 2022
care
carepass
carson
Our Take: CVS Health wins bidding contest with offer to acquire Signify Health for approximately $8 billion
Insight
Our Take Newsletter
September 12, 2022

Our Take: CVS Health wins bidding contest with offer to acquire Signify Health for approximately $8 billion

Learn More
September 12, 2022
cvs caremark
CVS
health
darwinhealth
healthcare
Our Take: Humana to acquire primary care centers opened in private equity JV for up to $550 million
Insight
Our Take Newsletter
September 26, 2022

Our Take: Humana to acquire primary care centers opened in private equity JV for up to $550 million

Learn More
September 26, 2022
Humana
acquisition
care
carepass
caregiver
Our Take: Eisai, Biogen’s lecanemab slowed clinical decline by 27% in Phase III Alzheimer’s trial
Insight
Our Take Newsletter
October 3, 2022

Our Take: Eisai, Biogen’s lecanemab slowed clinical decline by 27% in Phase III Alzheimer’s trial

Learn More
October 3, 2022
alzheimer
alzheimer's
pharma
biogen
Our Take: Amylyx’s investigational ALS drug gains FDA approval, but the controversy continues
Insight
Our Take Newsletter
October 10, 2022

Our Take: Amylyx’s investigational ALS drug gains FDA approval, but the controversy continues

Learn More
October 10, 2022
prescription drugs
drug
drugs
fda
Stay Aware. Stay Informed.

Want to strengthen your account planning?

Sign up for highly curated, expert weekly strategic insights for health care executives and leaders.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.